Literature DB >> 16547258

Small molecules that enhance the catalytic efficiency of HLA-DM.

Melissa J Nicholson1, Babak Moradi, Nilufer P Seth, Xuechao Xing, Gregory D Cuny, Ross L Stein, Kai W Wucherpfennig.   

Abstract

HLA-DM (DM) plays a critical role in Ag presentation to CD4 T cells by catalyzing the exchange of peptides bound to MHC class II molecules. Large lateral surfaces involved in the DM:HLA-DR (DR) interaction have been defined, but the mechanism of catalysis is not understood. In this study, we describe four small molecules that accelerate DM-catalyzed peptide exchange. Mechanistic studies demonstrate that these small molecules substantially enhance the catalytic efficiency of DM, indicating that they make the transition state of the DM:DR/peptide complex energetically more favorable. These compounds fall into two functional classes: two compounds are active only in the presence of DM, and binding data for one show a direct interaction with DM. The remaining two compounds have partial activity in the absence of DM, suggesting that they may act at the interface between DM and DR/peptide. A hydrophobic ridge in the DMbeta1 domain was implicated in the catalysis of peptide exchange because the activity of three of these enhancers was substantially reduced by point mutations in this area.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16547258      PMCID: PMC3412064          DOI: 10.4049/jimmunol.176.7.4208

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  35 in total

1.  A three-step kinetic mechanism for peptide binding to MHC class II proteins.

Authors:  R V Joshi; J A Zarutskie; L J Stern
Journal:  Biochemistry       Date:  2000-04-04       Impact factor: 3.162

Review 2.  Fluorescence polarization and anisotropy in high throughput screening: perspectives and primer.

Authors:  J C Owicki
Journal:  J Biomol Screen       Date:  2000-10

3.  The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.

Authors:  L Mosyak; D M Zaller; D C Wiley
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

4.  Crystal structure of mouse H2-M.

Authors:  D H Fremont; F Crawford; P Marrack; W A Hendrickson; J Kappler
Journal:  Immunity       Date:  1998-09       Impact factor: 31.745

5.  Analysis of protein-peptide interaction by a miniaturized fluorescence polarization assay using cyclin-dependent kinase 2/cyclin E as a model system.

Authors:  S S Pin; I Kariv; N R Graciani; K R Oldenburg
Journal:  Anal Biochem       Date:  1999-11-15       Impact factor: 3.365

6.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.

Authors:  J F Katz; C Stebbins; E Appella; A J Sant
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein.

Authors:  C J Harrington; A Paez; T Hunkapiller; V Mannikko; T Brabb; M Ahearn; C Beeson; J Goverman
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

8.  Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.

Authors:  M Krogsgaard; K W Wucherpfennig; B Cannella; B E Hansen; A Svejgaard; J Pyrdol; H Ditzel; C Raine; J Engberg; L Fugger; B Canella
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

9.  DM determines the cryptic and immunodominant fate of T cell epitopes.

Authors:  N K Nanda; A J Sant
Journal:  J Exp Med       Date:  2000-09-18       Impact factor: 14.307

10.  Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.

Authors:  K J Smith; J Pyrdol; L Gauthier; D C Wiley; K W Wucherpfennig
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  28 in total

1.  Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association.

Authors:  Gijsbert M Grotenbreg; Melissa J Nicholson; Kevin D Fowler; Kathrin Wilbuer; Leah Octavio; Maxine Yang; Arup K Chakraborty; Hidde L Ploegh; Kai W Wucherpfennig
Journal:  J Biol Chem       Date:  2007-05-24       Impact factor: 5.157

2.  Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4+ T cell activation.

Authors:  Miguel Álvaro-Benito; Eliot Morrison; Friederike Ebner; Esam T Abualrous; Marie Urbicht; Marek Wieczorek; Christian Freund
Journal:  Cell Mol Immunol       Date:  2018-11-22       Impact factor: 11.530

3.  Structure-based selection of small molecules to alter allele-specific MHC class II antigen presentation.

Authors:  Aaron W Michels; David A Ostrov; Li Zhang; Maki Nakayama; Masanori Fuse; Kristen McDaniel; Bart O Roep; Peter A Gottlieb; Mark A Atkinson; George S Eisenbarth
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

4.  Molecular and structural determinants of adamantyl susceptibility to HLA-DRs allelic variants: an in silico approach to understand the mechanism of MLEs.

Authors:  Waqasuddin Khan
Journal:  J Comput Aided Mol Des       Date:  2010-11-30       Impact factor: 3.686

5.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

Review 6.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

7.  Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.

Authors:  Oliver G Goldstein; Laela M Hajiaghamohseni; Shereen Amria; Kumaran Sundaram; Sakamuri V Reddy; Azizul Haque
Journal:  Cancer Immunol Immunother       Date:  2008-03-15       Impact factor: 6.968

Review 8.  Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

Review 9.  Measurement of Peptide Binding to MHC Class II Molecules by Fluorescence Polarization.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  Curr Protoc Immunol       Date:  2014-08-01

10.  Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE).

Authors:  Katharina Dickhaut; Sabine Hoepner; Jamina Eckhard; Karl-Heinz Wiesmueller; Luise Schindler; Guenther Jung; Kirsten Falk; Olaf Roetzschke
Journal:  PLoS One       Date:  2009-09-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.